$ETST Gabriel Aviles, ETST’s Chief Sales Officer & Director states, “I’ve received extensive positive feedback on our oil and it’s a privilege to have been engaged by such amazing, passionate professionals within the field. This formula is something that I have known about and been wanting to study further for some time. Thanks to ETST and its advisory board members, I am confident that our new formula can prove to be a way to aid and relieve symptoms suffered in our current opioid epidemic. Not only will our potential patent-pending CBD formula help many addicts, it’ll give us a niche in the CBD space, alongside our other three patent pending products that we plan to launch soon.”
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!